EMA — authorised 18 February 2011
- Marketing authorisation holder: Teva Pharma B.V.
- Status: approved
EMA authorised Comtan on 18 February 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 18 February 2011.
Teva Pharma B.V. holds the EU marketing authorisation.